Evela Health
Evela Health is a Berlin-based digital health company operating a CE-marked Class I medical device platform that delivers personalized menopause and perimenopause care — including symptom tracking, specialist video consultations, and evidence-based content — to women 40+ across the DACH region via D2C, B2B employers, and insurance partnerships.
- Company typePrivate
- Founded2023
- HeadquartersBerlin, Germany
- Headcount1–10
- GTM typeB2C
- OfferingSoftware
What Evela Health does
Evela Health GmbH is a Berlin-based digital health company founded in 2023 that delivers a CE-marked, Class I medical device platform for women in perimenopause and menopause. The platform, available as a web application and native iOS/Android apps, combines structured symptom tracking via the validated Menopause Rating Scale II (MRS II), an evidence-based educational content hub called Evela Campus, ML-driven personalization for therapy pathway optimization under the N-of-1 principle, and video consultations with certified menopause specialists. Partnering physicians can issue private prescriptions when medically necessary, and the product is designed to comply with EU MDR plus the ISO 13485 / IEC 62304 / IEC 82304-1 stack.
The company operates a primarily direct-to-consumer model with a freemium entry tier and two paid offerings: Evela Premium at €239/year (two specialist consultations, personalized health plan, unlimited premium content, prescription access) and Evela Clarity at €99 as a one-time consultation option creditable toward Premium. Distribution extends through a dedicated B2B employer channel and a network of insurance partners — HanseMerkur, DAK Hamburg (statutory pilot under § 140a SGB V), ARAG, INTER, Atupri (Switzerland), and Wiener Städtische (Austria) — which underwrite Premium costs for eligible insured women 40+ across the DACH region. Revenue is not publicly disclosed.
Evela Health has secured grant funding via the Berlin/EFRE ProFIT program (2023) and additional 2025 rounds totaling approximately $3.04M from Investitionsbank Berlin, better ventures, and Impact Shakers. The company is led by co-founders Dr. Valerie Kirchberger and Eva-Maria Meijnen (Co-CEOs), with PD Dr. Cornelius Remschmidt as Chief Science Officer / Medical Director and Emilio De Lazzari as CTO; the team numbers fewer than ten people and serves an addressable population estimated at roughly 9 million women in Germany and 47 million women globally entering menopause each year.
Evela Health firmographics
Firmographics- Name
- Evela Health
- Legal name
- Evela Health GmbH
- Website
- https://evela.health
- Company type
- Private
- Founded year
- 2023
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Evela Health is a Berlin-based digital health company operating a CE-marked Class I medical device platform that delivers personalized menopause and perimenopause care — including symptom tracking, specialist video consultations, and evidence-based content — to women 40+ across the DACH region via D2C, B2B employers, and insurance partnerships.
- Ownership category
- akta.pro rank
Evela Health industry classification
Industry- Product category
- Digital Menopause Care
- NAICS
- Offices of Physicians (6211)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Women’s Health & Fertility Therapeutics (Digital) (HLACANAK)
- akta.pro secondary industries
- Sexual & Pelvic Health Telehealth (STI care, pelvic pain, endometriosis/PCOS support) (HLALAHAJ), Maternal, Women’s & Family Virtual Care Programs (Payer-Sponsored) (HLALACAJ), 24/7 Nurse Line, Symptom Checker & Triage (Payer-Sponsored) (HLALACAB)
Keywords
Where Evela Health is headquartered
LocationHeadquarters
- HQ city
- Berlin
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
Evela Health business model
Business model- GTM type
- B2C
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Others
Revenue model
- Evela Premium Subscription: Annual subscription at €239/year (or €19.90/month). Includes 2 video consultations with menopause specialists, personalized health plans, unlimited access to premium campus content, email support, and private prescriptions when medically necessary through partnering physicians.
- Evela Clarity: One-time purchase at €99 for single video consultation and health plan. If user upgrades to Premium, the €99 is credited.
- Insurance Reimbursement: Insurance partners reimburse Premium costs. HanseMerkur (100% for women 45+), ARAG (100% for women 40+), INTER (100% for women 40+), Atupri (up to 80% for women 40+ in Switzerland), DAK Hamburg (100% pilot program for women 45-60).
- Gift Vouchers: Premium gift vouchers sold at €239 (same as annual Premium price). Recipient redeems code for free Premium access.
- B2B/Employer Access: Corporate offerings for employers to provide menopause support as employee benefit. Referenced on website with dedicated 'Für Unternehmen' (For Companies) section.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Pay-as-you-go | Free Registration - Basic Access |
| Subscription | Annual | Evela Premium - Full Program Access |
| One time/ perpetual license | Pay-as-you-go | Evela Clarity - Single Consultation |
| Subscription | Annual | DAK Hamburg Pilot - Free Access |
| Subscription | Annual | Wiener Städtische - Insurance Covered |
| Subscription | Annual | Atupri Switzerland - Up to 80% Covered |
| Subscription | Annual | ARAG - 100% Covered |
| Subscription | Annual | HanseMerkur - Up to 100% Covered |
| Subscription | Annual | INTER - Up to 100% Covered |
Go-to-market motion3 records
Distribution channels11 records
Marketing channels15 records
Evela Health product offering
Product offeringCore offering
Evela Health operates a CE-marked Class I medical device digital health platform for women in perimenopause and menopause. The platform combines structured symptom tracking via the validated Menopause Rating Scale II (MRS II), a comprehensive Health Assessment Questionnaire, and machine-learning-driven personalization with video consultations delivered by certified menopause specialists. It is offered as a subscription (Evela Premium at €239/year) and a one-time consultation option (Evela Clarity at €99), supported by the Evela Campus educational content library.
Product overview
Evela Health offers a digital healthcare platform specifically designed for women in midlife experiencing menopause. The core offering is the Evela Health Platform, available as a browser-based web application and native mobile apps for iOS and Android. The platform is complemented by two service tiers: Evela Premium (239 EUR/year subscription) provides two video consultations with certified menopause therapists, personalized health plans, unlimited premium content access via Evela Campus, and access to private prescriptions from partnering physicians; while Evela Clarity offers a one-time 99 EUR consultation option for those seeking initial guidance. The Evela Campus delivers evidence-based educational content across multiple formats. Gift vouchers are available to share Premium access with others.
Differentiator
Problem solved
Functional benefit
Products and services
- Evela Health Platform Browser-based and native iOS/Android digital health application that provides structured symptom tracking using the validated Menopause Rating Scale II (MRS II), Health Assessment Questionnaire, educational content access, and booking of video consultations with certified menopause therapists for women in perimenopause and menopause.
- Evela Premium Annual subscription at €239/year (or €19.90/month) providing two video consultations with certified menopause specialists, an in-depth Health Assessment, personalized health plans, unlimited premium Campus content, email support, and private prescriptions via partnering physicians when medically necessary.
- Evela Clarity One-time €99 product offering a single video consultation with a certified menopause specialist plus a personalized health plan; the €99 fee is credited toward Evela Premium if the user upgrades.
- Evela Gift Voucher
Quantifiable outcome
- Symptom tracking accuracy using validated MRS II instrument
- +1 more outcomes
Companies that use Evela Health
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles3 records
Evela Health technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration6 records
AI capability5 records
Feature6 records
Evela Health partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core and minor.
- HanseMerkur KrankenversicherungcoreHanseMerkur covers up to 100% of Evela Premium costs (€239/year) for insured women over 45 years according to tariff. Users purchase then submit invoice for reimbursement.
- DAK-Gesundheit HamburgcoreDAK-Gesundheit pilot program provides 100% covered Evela Premium for women aged 45-60 in Hamburg under § 140a SGB V (Vertrag zur Besonderen Versorgung).
- ARAG KrankenversicherungcoreARAG covers 100% of Evela Premium costs for fully insured women over 40 as a service benefit. Coverage does not affect insurance premium or deductible.
- INTER VersicherungsgruppecoreINTER Insurance Group covers up to 100% of Evela Premium costs for fully insured women over 40 according to tariff. Users purchase then submit invoice for reimbursement.
- Atupri Krankenkasse (Switzerland)minorAtupri (Switzerland) covers up to 80% of Evela Premium costs (CHF 239) for insured women 40+ with supplementary insurance. Users pay then submit invoice for reimbursement.
- Wiener Städtische Versicherung (Austria)minorWiener Städtische (Austria) covers Evela Premium costs up to 100% for fully insured women over 40 years. Uses voucher code system where users request code from insurance then redeem on Evela platform.
- Technical University Munich (TUM)minorTUM shown in partner logos, potentially related to academic research collaboration or medical advisory.
- Stayoung / Nina RugeminorPartnership with Nina Ruge's Stayoung platform for reaching health-conscious women 40+. Content collaboration including article contributions and newsletter mentions.
Scale indicators7 records
Recent moves6 records
Expansion highlights8 records
Evela Health competitors and assessment
Company assessmentDirect peers
- Midi Health: US-based virtual care clinic focused exclusively on perimenopause and menopause, offering video visits with menopause-trained clinicians, hormone therapy, and personalized care plans. Most direct head-to-head competitor to Evela's specialist-led, evidence-based menopause model, albeit in a different geography and reimbursement system.
- Elektra Health: US digital menopause platform combining telemedicine with menopause specialists, evidence-based education, and community. Closely comparable to Evela in clinical hybrid model, validated content approach, and B2B/employer distribution strategy.
- Evernow: US telehealth provider for menopause care offering consultations, prescriptions, and ongoing support from clinicians. Direct competitor on the menopause-telehealth care delivery model Evela operates in Germany and DACH.
- Peppy: UK-based employee benefits provider offering menopause (and other life-stage) support as a workplace benefit with expert practitioners. Comparable to Evela's employer-sponsored B2B motion and clinical specialist model, though Peppy is B2B-first and multi-condition.
- Gennev: US menopause telehealth platform offering physician-led consultations, treatment plans, and ongoing care. Operates the same menopause-specialist + digital platform hybrid that Evela delivers in DACH.
- Winona: US menopause treatment provider offering physician consultations and hormone replacement therapy. Overlaps with Evela's specialist consultations, personalized plans, and private prescription pathway.
Broad incumbents
- Maven Clinic: Global virtual care platform for women's and family health covering fertility, pregnancy, postpartum, and increasingly menopause. Broader portfolio than Evela but overlaps on women's health specialty telehealth and B2B employer/insurer distribution.
- Tia: US women's health primary care provider blending in-person clinics with virtual care. Comparable on women-focused care delivery and clinical specialist model; broader scope than Evela's menopause-specific positioning.
- Hims & Hers: Large-scale direct-to-consumer telehealth platform that has expanded into women's health and hormone-related care. Comparable on D2C subscription model and consumer telehealth infrastructure, but operating in a much broader condition portfolio.
Emerging players
- Oura: Consumer wearable ring with women's health features including cycle, fertility, and menopause insights. Comparable to Evela's wearable data integration and symptom-tracking element, though Oura is a hardware-first consumer brand rather than a clinical care provider.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Evela Health social profiles
Digital presenceEvela Health compliance and trust
Trust signalCompliance11 records
Evela Health financial estimates
Financial estimateRevenue estimate
Valuation estimate
Evela Health leadership team
Management profileNumber of profiles
Profiles5 records
Evela Health funding detail
Funding detailFunding overview
Funding rounds3 records
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Evela Health M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Evela Health
What does Evela Health do?
Evela Health operates a CE-marked Class I medical device digital health platform for women in perimenopause and menopause. The platform combines structured symptom tracking via the validated Menopause Rating Scale II (MRS II), a comprehensive Health Assessment Questionnaire, and machine-learning-driven personalization with video consultations delivered by certified menopause specialists. It is offered as a subscription (Evela Premium at €239/year) and a one-time consultation option (Evela Clarity at €99), supported by the Evela Campus educational content library.
Is Evela Health a public or private company?
Evela Health is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Evela Health founded?
Evela Health was founded in 2023. It employs 1 to 10 people.
Where is Evela Health based?
Evela Health is headquartered in Berlin, Germany, in the Europe region.
How does Evela Health make money?
Five revenue lines are on record. Evela Premium Subscription is the primary driver. The others are evela Clarity, insurance Reimbursement, gift Vouchers and B2B/Employer Access.
Who are Evela Health's main competitors?
Direct peers on record are Midi Health, Elektra Health, Evernow, Peppy, Gennev and Winona. Broad incumbents are Maven Clinic, Tia and Hims & Hers. Oura is listed as an emerging player.
Does Evela Health have an API?
No public API is recorded for Evela Health.
What industry is Evela Health in?
Evela Health's product category is Digital Menopause Care. Its primary akta.pro industry code is HLACANAK, Women’s Health & Fertility Therapeutics (Digital), with a secondary code of HLALAHAJ, Sexual & Pelvic Health Telehealth (STI care, pelvic pain, endometriosis/PCOS support). Its NAICS code is 6211 and its SIC code is 8011.